Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
ESSEPA research illustrates the current state of safeguarding in university sport
EIN Presswire
The research reveals a paradox: while the frameworks often assume safety, participants on the ground report a fragmented system with unclear reporting and gaps.
The European Magazine Releases Its Summer 2026 Edition
EIN Presswire
The Summer 2026 edition of The European is out now. Order your print or digital copy for exclusive interviews, expert analysis and global insights.
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
GlobeNewswire, Inc.
- Positive CHMP opinion supports potential commercialization of obicetrapib monotherapy and obicetrapib/ezetimibe fixed-dose combination in Europe - - Recommendation based on positive Phase 3 BROADWAY, BROOKLYN, and TANDEM data - - European...
St. Kitts and Nevis enters New Space through historic life sciences mission with Switzerland
EIN Presswire
Caribbean–Swiss partnership launches space biology experiment to advance STEM education, research capacity, and international collaboration.
Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing
GlobeNewswire, Inc.
Healthcare Holding Schweiz AG, a leading Swiss service provider and distributor of medical technology, has successfully closed a CHF 80 million syndicated financing.
Dental Laboratories Market Set to Reach USD 13.09 Billion by 2030 | MarketsandMarkets™
GlobeNewswire, Inc.
Delray Beach, FL, March 30, 2026 (GLOBE NEWSWIRE) -- The global dental laboratories market, valued at US$8.66 billion in 2024, stood at US$9.20 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2030, culminating...
4BIO Capital strengthens investment leadership with appointment of Therese Liechtenstein as Partner and Tetsu Maruyama as Venture Partner
GlobeNewswire, Inc.
Thera Liechtenstein brings extensive biotech investment and company‑building experience to new role as Partner at 4BIO Capital Tetsu Maruyama, former Head of Drug Discovery at Takeda Pharmaceuticals, appointed as Venture Partner London, United...
Abaxx Technologies Acquires Strategic Position in ARTEX AG, Extending Capabilities in Europe and to New Markets in Fine Art
GlobeNewswire, Inc.
TORONTO and VADUZ, Liechtenstein, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (CBOE:ABXX) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner...
OSCE training empowers young experts from Central Asia, South-East Europe and Mediterranean Partners for Co-operation regions in inclusive project design and digital research
Organization for Security and Co-operation in Europe
From 14 to 17 November, the OSCE Secretariat, in partnership with the OSCE Academy in Bishkek, gathered 26 young experts from Central Asia, South-East Europe and Mediterranean Partners for Co-operation regions for a dynamic four-day seminar in...
SEALSQ and Kaynes SemiCon Announce Joint Venture to Establish India's First Secure Semiconductor Center for Onshore Personalization and Quantum-Resistant Technology
GlobeNewswire, Inc.
Geneva, Switzerland / India, Sept. 29, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products,,...
AMERICAN SWISS FOUNDATION HOSTS 2026 LEADERSHIP SUMMIT IN RÜSCHLIKON, SWITZERLAND
EIN Presswire
"U.S.–Swiss Leadership in Technological Advancements” RÜSCHLIKON, ZÜRICH, SWITZERLAND, June 26, 2026 /EINPresswire.com/ -- On June 16–17, 2026, the American Swiss Foundation convened its annual Leadership Summit at the Swiss Re Centre for Global...
SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma
GlobeNewswire, Inc.
BRUSSELS, July 01, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company designed to address rare and urgent conditions, today announced that it has completed the acquisition of exclusive development and...
Coatings And Application Technologies For Robotics Market To Reach $33.95 Billion By 2029 At 10.6% CAGR: TBRC
EIN Presswire
The Business Research Company's Coatings And Application Technologies For Robotics Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 2, 2025 /EINPresswire.com/ -- "Get 30%...
CEO Insight examines the strategies shaping global investment, finance and economic resilience
EIN Presswire
LONDON, UNITED KINGDOM, July 15, 2026 /EINPresswire.com/ -- The latest edition of CEO Insight explores how governments, financial institutions and business leaders are responding to a rapidly evolving global economy, where geopolitical...
Syncron Appoints Bianka Hay-Falk as Chief Human Resources Officer
GlobeNewswire, Inc.
STOCKHOLM, June 23, 2026 (GLOBE NEWSWIRE) -- Syncron, a global leader in intelligent aftermarket solutions, today announced the appointment of Bianka Hay-Falk as Chief Human Resources Officer.
Virella Files European Patent Application for Novel SIRT6 Small-Molecule Activators
EIN Presswire
Liechtenstein-based biotech company reports significant lifespan extension in C. elegans and advances toward preclinical development with CRO partners SCHAAN, LIECHTENSTEIN, April 3, 2026 /EINPresswire.com/ -- Virella Ltd, a European biotech...
Fire Stopping Materials Market worth $2.47 billion by 2030, at 5.7%, says MarketsandMarkets™
GlobeNewswire, Inc.
Delray Beach, FL, June 18, 2026 (GLOBE NEWSWIRE) -- In terms of value, the Fire Stopping Materials Market projected to grow from USD 1.87 billion in 2025 and to reach USD 2.47 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 5.7% during...
European Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union
GlobeNewswire, Inc.
Joenja® (leniolisib) is first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency, in adult and pediatric patients aged 12 years and older First European...
SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million
GlobeNewswire, Inc.
BRUSSELS, May 19, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals (“SERB”) and Hansa Biopharma AB (“Hansa”) (Nasdaq Stockholm: HNSA) today announced that they have entered into an agreement under which SERB will acquire the exclusive development and...
European Commission’s Approval of CinnaGen’s Teriparatide Signals New Phase of Global Growth
EIN Presswire
The European Commission’s authorization of Zandoriah®, an osteoporosis medication, marks a significant step in CinnaGen’s journey of international expansion DUBAI, DUBAI, UNITED ARAB EMIRATES, July 3, 2026 /EINPresswire.com/ -- July 02, 2026:...
Sign up for:
Technology Week Liechtenstein
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.